Poly(ADP-ribose) polymerase 1 activation is required for cisplatin nephrotoxicity

Kidney International

Volumn 82, Issue 2, 2012, Pages 193-203

  Kim, Jinu ^a   Long, Kelly E ^a   Tang, Kang ^a   Padanilam, Babu J ^a,b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CISPLATIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; MITOGEN ACTIVATED PROTEIN KINASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE INHIBITOR; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEATH; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; MOUSE; NEPHROTOXICITY; NEUTROPHIL CHEMOTAXIS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; RENAL PROTECTION; UPREGULATION;

EID: 84863326477     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2012.64     Document Type: Article

References (70)

1. Wang D, Lippard SJ. Cellular processing of platinum anticancer drugs. Nat Rev 2005; 4: 307-320.
2. Siddik ZH. Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene 2003; 22: 7265-7279.
3. Arany I, Safirstein RL. Cisplatin nephrotoxicity. Semin Nephrol 2003; 23: 460-464.
4. Pabla N, Dong Z. Cisplatin nephrotoxicity: mechanisms and renoprotective strategies. Kidney Int 2008; 73: 994-1007.
5. Pabla N, Murphy RF, Liu K et al. The copper transporter Ctr1 contributes to cisplatin uptake by renal tubular cells during cisplatin nephrotoxicity. Am J Physiol Renal Physiol 2009; 296: F505-F511.
6. Lieberthal W, Triaca V, Levine J. Mechanisms of death induced by cisplatin in proximal tubular epithelial cells: apoptosis vs. necrosis. Am J Physiol 1996; 270: F700-F708.
7. Pabla N, Huang S, Mi QS et al. ATR-Chk2 signaling in p53 activation and DNA damage response during cisplatin-induced apoptosis. J Biol Chem 2008; 283: 6572-6583.
8. Yang C, Kaushal V, Shah SV et al. Autophagy is associated with apoptosis in cisplatin injury to renal tubular epithelial cells. Am J Physiol 2008; 294: F777-F787.
9. Dong G, Luo J, Kumar V et al. Inhibitors of histone deacetylases suppress cisplatin-induced p53 activation and apoptosis in renal tubular cells. Am J Physiol 2010; 298: F293-F300.
10. Ramesh G, Reeves WB. TNF-alpha mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity. J Clin Invest 2002; 110: 835-842.
11. Zhang B, Ramesh G, Uematsu S et al. TLR4 signaling mediates inflammation and tissue injury in nephrotoxicity. J Am Soc Nephrol 2008; 19: 923-932.
12. Kraus WL, Lis JT. PARP goes transcription. Cell 2003; 113: 677-683.
13. Krishnakumar R, Gamble MJ, Frizzell KM et al. Reciprocal binding of PARP-1 and histone H1 at promoters specifies transcriptional outcomes. Science 2008; 319: 819-821.
14. Liaudet L, Pacher P, Mabley JG et al. Activation of poly(ADP-Ribose) polymerase-1 is a central mechanism of lipopolysaccharide-induced acute lung inflammation. Am J Respir Crit Care Med 2002; 165: 372-377.
15. Zerfaoui M, Errami Y, Naura AS et al. Poly(ADP-ribose) polymerase-1 is a determining factor in Crm1-mediated nuclear export and retention of p65 NF-kappa B upon TLR4 stimulation. J Immunol 2010; 185: 1894-1902.
16. Ha HC, Hester LD, Snyder SH. Poly(ADP-ribose) polymerase-1 dependence of stress-induced transcription factors and associated gene expression in glia. Proc Natl Acad Sci USA 2002; 99: 3270-3275.
17. Ha HC, Snyder SH. Poly(ADP-ribose) polymerase is a mediator of necrotic cell death by ATP depletion. Proc Natl Acad Sci USA 1999; 96: 13978-13982.
18. Moubarak RS, Yuste VJ, Artus C et al. Sequential activation of poly(ADPribose) polymerase 1, calpains, and Bax is essential in apoptosis-inducing factor-mediated programmed necrosis. Mol Cell Biol 2007; 27: 4844-4862.
19. Martin DR, Lewington AJ, Hammerman MR et al. Inhibition of poly(ADP-ribose) polymerase attenuates ischemic renal injury in rats. Am J Physiol Regul Integr Comp Physiol 2000; 279: R1834-R1840.
20. Devalaraja-Narashimha K, Padanilam BJ. PARP-1 inhibits glycolysis in ischemic kidneys. J Am Soc Nephrol 2009; 20: 95-103.
21. Shevalye H, Stavniichuk R, Xu W et al. Poly(ADP-ribose) polymerase (PARP) inhibition counteracts multiple manifestations of kidney disease in long-term streptozotocin-diabetic rat model. Biochem Pharmacol 2010; 79: 1007-1014.
22. Kim J, Padanilam BJ. Loss of poly(ADP-ribose) polymerase 1 attenuates renal fibrosis and inflammation during unilateral ureteral obstruction. Am J Physiol Renal Physiol 2011; 301: F450-F459.
23. Xu Y, Huang S, Liu ZG et al. Poly(ADP-ribose) polymerase-1 signaling to mitochondria in necrotic cell death requires RIP1/TRAF2-mediated JNK1 activation. J Biol Chem 2006; 281: 8788-8795.
24. Racz B, Hanto K, Tapodi A et al. Regulation of MKP-1 expression and MAPK activation by PARP-1 in oxidative stress: a new mechanism for the cytoplasmic effect of PARP-1 activation. Free Radic Biol Med 2010; 49: 1978-1988.
25. Ramesh G, Reeves WB. p38 MAP kinase inhibition ameliorates cisplatin nephrotoxicity in mice. Am J Physiol Renal Physiol 2005; 289: F166-F174.
26. Francescato HD, Costa RS, Junior FB et al. Effect of JNK inhibition on cisplatin-induced renal damage. Nephrol Dial Transplant 2007; 22: 2138-2148.
27. Ramesh G, Reeves WB. Salicylate reduces cisplatin nephrotoxicity by inhibition of tumor necrosis factor-alpha. Kidney Int 2004; 65: 490-499.
28. Chiarugi A, Moskowitz MA. Poly(ADP-ribose) polymerase-1 activity promotes NF-kappaB-driven transcription and microglial activation: implication for neurodegenerative disorders. J Neurochem 2003; 85: 306-317.
29. Ventura JJ, Cogswell P, Flavell RA et al. JNK potentiates TNF-stimulated necrosis by increasing the production of cytotoxic reactive oxygen species. Genes Dev 2004; 18: 2905-2915.
30. Liu H, Baliga R. Cytochrome P450 2E1 null mice provide novel protection against cisplatin-induced nephrotoxicity and apoptosis. Kidney Int 2003; 63: 1687-1696.
31. Yao X, Panichpisal K, Kurtzman N et al. Cisplatin nephrotoxicity: a review. Am J Med Sci 2007; 334: 115-124.
32. Wei Q, Dong G, Franklin J et al. The pathological role of Bax in cisplatin nephrotoxicity. Kidney Int 2007; 72: 53-62.
33. Shino Y, Itoh Y, Kubota T et al. Role of poly(ADP-ribose) polymerase in cisplatin-induced injury in LLC-PK1 cells. Free Radic Biol Med 2003; 35: 966-977.
34. Simbulan-Rosenthal CM, Rosenthal DS, Iyer S et al. Involvement of PARP and poly(ADP-ribosyl)ation in the early stages of apoptosis and DNA replication. Mol Cell Biochem 1999; 193: 137-148.
35. Oliver FJ, de la Rubia G, Rolli V et al. Importance of poly(ADP-ribose) polymerase and its cleavage in apoptosis. Lesson from an uncleavable mutant. J Biol Chem 1998; 273: 33533-33539.
36. Filipovic DM, Meng X, Reeves WB. Inhibition of PARP prevents oxidantinduced necrosis but not apoptosis in LLC-PK1 cells. Am J Physiol 1999; 277: F428-F436.
37. Zheng J, Devalaraja-Narashimha K, Singaravelu K et al. Poly(ADP-ribose) polymerase-1 gene ablation protects mice from ischemic renal injury. Am J Physiol 2005; 288: F387-F398.
38. Zhou HZ, Swanson RA, Simonis U et al. Poly(ADP-ribose) polymerase-1 hyperactivation and impairment of mitochondrial respiratory chain complex I function in reperfused mouse hearts. Am J Physiol Heart Circ Physiol 2006; 291: H714-H723.
39. Lai Y, Chen Y, Watkins SC et al. Identification of poly-ADP-ribosylated mitochondrial proteins after traumatic brain injury. J Neurochem 2008; 104: 1700-1711.
40. Pankotai E, Lacza Z, Muranyi M et al. Intra-mitochondrial poly(ADP-ribosyl)ation: potential role for alpha-ketoglutarate dehydrogenase. Mitochondrion 2009; 9: 159-164.
41. Zhang B, Ramesh G, Norbury CC et al. Cisplatin-induced nephrotoxicity is mediated by tumor necrosis factor-alpha produced by renal parenchymal cells. Kidney Int 2007; 72: 37-44.
42. Faubel S, Lewis EC, Reznikov L et al. Cisplatin-induced acute renal failure is associated with an increase in the cytokines interleukin (IL)-1beta, IL-18, IL-6, and neutrophil infiltration in the kidney. J Pharmacol Exp Ther 2007; 322: 8-15.
43. Adams DC, Karolak MJ, Larman BW et al. Follistatin-like 1 regulates renal IL-1beta expression in cisplatin nephrotoxicity. Am J Physiol 2010; 299: F1320-F1327.
44. Mabley JG, Jagtap P, Perretti M et al. Anti-inflammatory effects of a novel, potent inhibitor of poly (ADP-ribose) polymerase. Inflamm Res 2001; 50: 561-569.
45. Goligorsky MS. TLR4 and HMGB1: partners in crime? Kidney Int 2011; 80: 450-452.
46. Wei M, Burenkova O, Lippard SJ. Cisplatin sensitivity in Hmbg1-/-and Hmbg1 ++ mouse cells. J Biol Chem 2003; 278: 1769-1773.
47. Morgan MJ, Kim YS, Liu ZG. TNFalpha and reactive oxygen species in necrotic cell death. Cell Res 2008; 18: 343-349.
48. Tsuruya K, Ninomiya T, Tokumoto M et al. Direct involvement of the receptor-mediated apoptotic pathways in cisplatin-induced renal tubular cell death. Kidney Int 2003; 63: 72-82.
49. Lee S, Kim W, Moon SO et al. Rosiglitazone ameliorates cisplatin-induced renal injury in mice. Nephrol Dial Transplant 2006; 21: 2096-2105.
50. Li S, Gokden N, Okusa MD et al. Anti-inflammatory effect of fibrate protects from cisplatin-induced ARF. Am J Physiol 2005; 289: F469-F480.
51. Chang WJ, Alvarez-Gonzalez R. The sequence-specific DNA binding of NF-kappa B is reversibly regulated by the automodification reaction of poly (ADP-ribose) polymerase 1. J Biol Chem 2001; 276: 47664-47670.
52. Hassa PO, Hottiger MO. The functional role of poly(ADP-ribose) polymerase 1 as novel coactivator of NF-kappaB in inflammatory disorders. Cell Mol Life Sci 2002; 59: 1534-1553.
53. Arany I, Megyesi JK, Kaneto H et al. Cisplatin-induced cell death is EGFR/src/ERK signaling dependent in mouse proximal tubule cells. Am J Physiol Renal Physiol 2004; 287: F543-F549.
54. Chang L, Karin M. Mammalian MAP kinase signalling cascades. Nature 2001; 410: 37-40.
55. Ha HC. Defective transcription factor activation for proinflammatory gene expression in poly(ADP-ribose) polymerase 1-deficient glia. Proc Natl Acad Sci USA 2004; 101: 5087-5092.
56. Mester L, Szabo A, Atlasz T et al. Protection against chronic hypoperfusion-induced retinal neurodegeneration by PARP inhibition via activation of PI-3-kinase Akt pathway and suppression of JNK and p38 MAP kinases. Neurotoxicity Res 2009; 16: 68-76.
57. Ramesh G, Brian Reeves W. Cisplatin increases TNF-alpha mRNA stability in kidney proximal tubule cells. Ren Fail 2006; 28: 583-592.
58. Zhang S, Lin ZN, Yang CF et al. Suppressed NF-kappaB and sustained JNK activation contribute to the sensitization effect of parthenolide to TNF-alpha-induced apoptosis in human cancer cells. Carcinogenesis 2004; 25: 2191-2199.
59. Song HY, Regnier CH, Kirschning CJ et al. Tumor necrosis factor (TNF)-mediated kinase cascades: bifurcation of nuclear factor-kappaB and c-jun N-terminal kinase (JNK/SAPK) pathways at TNF receptor-associated factor 2. Proc Natl Acad Sci USA 1997; 94: 9792-9796.
60. Kagawa T, Takao T, Horino T et al. Angiotensin II receptor blocker inhibits tumour necrosis factor-alpha-induced cell damage in human renal proximal tubular epithelial cells. Nephrology 2008; 13: 309-315.
61. Zhang S, Lin Y, Kim YS et al. c-Jun N-terminal kinase mediates hydrogen peroxide-induced cell death via sustained poly(ADP-ribose) polymerase-1 activation. Cell Death Differ 2007; 14: 1001-1010.
62. Kim J, Kil IS, Seok YM et al. Orchiectomy attenuates post-ischemic oxidative stress and ischemia/reperfusion injury in mice. A role for manganese superoxide dismutase. J Biol Chem 2006; 281: 20349-20356.
63. Kim J, Kim KY, Jang HS et al. Role of cytosolic NADP+-dependent isocitrate dehydrogenase in ischemia-reperfusion injury in mouse kidney. Am J Physiol Renal Physiol 2009; 296: F622-F633.
64. Kim J, Kim JI, Jang HS et al. Protective role of cytosolic NADP(+)-dependent isocitrate dehydrogenase, IDH1, in ischemic pre-conditioned kidney in mice. Free Radic Res 2011; 45: 759-766.
65. Kim J, Jang HS, Park KM. Reactive oxygen species generated by renal ischemia and reperfusion trigger protection against subsequent renal ischemia and reperfusion injury in mice. Am J Physiol Renal Physiol 2010; 298: F158-F166.
66. Kim J, Park JW, Park KM. Increased superoxide formation induced by irradiation preconditioning triggers kidney resistance to ischemiareperfusion injury in mice. Am J Physiol Renal Physiol 2009; 296: F1202-F1211.
67. Kohli V, Madden JF, Bentley RC et al. Calpain mediates ischemic injury of the liver through modulation of apoptosis and necrosis. Gastroenterology 1999; 116: 168-178.
68. Kim J, Jung KJ, Park KM. Reactive oxygen species differently regulate renal tubular epithelial and interstitial cell proliferation after ischemia and reperfusion injury. Am J Physiol 2010; 298: F1118-F1129.
69. Kim J, Kim DS, Park MJ et al. Omi/HtrA2 protease is associated with tubular cell apoptosis and fibrosis induced by unilateral ureteral obstruction. Am J Physiol Renal Physiol 2010; 298: F1332-F1340.
70. Kim J, Seok YM, Jung KJ et al. Reactive oxygen species/oxidative stress contributes to progression of kidney fibrosis following transient ischemic injury in mice. Am J Physiol Renal Physiol 2009; 297: F461-F470.